# Clinical Study: Gastrointestinal Bitter Taste Receptors Exhibit Inter-Regional and Inter-Individual Variation
**TYPE:** Primary Clinical Research (Preprint / Mechanism Study)
**STATUS:** Posted (Not Peer-Reviewed)
**TRIAL REGISTRY:** Human Biopsy Study (Ethics Approval NTY/11/08/077)
**ETHICS APPROVAL:** New Zealand Health and Disability Ethics (HEDC) (NTY/11/08/077)
**DOI:** [10.20944/preprints202410.1917.v1](https://doi.org/10.20944/preprints202410.1917.v1)
**JOURNAL:** Preprints.org
**AUTHORS:** Walker et al.
---
## Study Summary (TL;DR)
This study maps the location of bitter taste receptors (TAS2Rs) throughout the human gut using mucosal biopsies from 28 healthy volunteers.
**Key Findings:**
1. **Receptors are Everywhere:** TAS2Rs are present throughout the entire GI tract, not just the mouth.
2. **Target Validation:** The specific receptors targeted by Amarasate (TAS2R1, TAS2R14, TAS2R38) are highly expressed in the **Small Intestine**, validating the delayed-release delivery mechanism.
3. **"Gut Super-Tasters":** The study identified a subset of individuals (phenotypes) who possess a broader and more active repertoire of gut bitter receptors, suggesting some users may be "high responders" to bitter appetite suppressants.
## Full Text Content
### 1. Introduction
The gastrointestinal (GI) tract represents a major interface between the human body and the external environment, functioning as both a vessel for the digestion and absorption of dietary nutrients as well as acting as a major chemosensory organ [1]. Gut chemosensory mechanisms detect a diverse array of compounds present in the gut lumen and elicit changes to both local and whole-body homeostasis in response to the components detected.
These gut chemosensory responses are sensitive to both type and relative location of stimulus. For example, exposure of gastric tissue to taste modalities stimulates the release of the hunger-promoting hormone ghrelin [2,3], whereas the presence of these same tastes in the ileum can stimulate the release of the hunger-suppressing hormone glucagon-like peptide-1 (GLP-1) and decrease food consumption [3,4].
The gut chemosensory system includes the family of 25 bitter taste receptors (TAS2Rs) [9]. Extra-lingual gut TAS2Rs are present in the gut mucosa, including within specialized chemosensing enteroendocrine cells [12]. These cells release appetite-regulating hormones such as cholecystokinin (CCK), GLP-1, and peptide YY (PYY) [13,14]. This study aimed to map the regional variation of these receptors to better understand their role in GI function and the gut-brain axis.
### 2. Materials and Methods
**2.1. Participants**
Mucosal biopsies were collected from 28 healthy volunteers (14 Male, 14 Female; Mean Age 47.2 years; Mean BMI 25.8 kg/m²) undergoing routine screening by gastroscopy or colonoscopy. Participants had no previous gut disorders.
**2.2. Biopsy Sampling**
300 biopsies were taken from 10 distinct regions:
* **Upper Gut:** Stomach (Fundus, Body, Antrum), Duodenum (D2), Proximal Jejunum.
* **Lower Gut:** Terminal Ileum, Ascending Colon, Transverse Colon, Sigmoid Colon, Rectum.
**2.3. Analysis**
Nanostring™ analysis was used to count RNA transcripts of TAS2Rs. This method is highly sensitive and allows for the detection of lowly expressed receptors.
### 3. Results
**3.1. TAS2R Transcription Profile (Table 2)**
TAS2Rs showed a diverse transcription profile throughout the human GI tract.
* **Highest Expression:** The most highly transcribed receptor was **TAS2R14** (Average count 1356), followed by the TAS2R43 sub-family (Average count 1274).
* **Regional Variation:**
* **TAS2R38, 40, 41, 60:** Significantly higher expression in the **Small Intestine** (Duodenum, Jejunum, Ileum) compared to the stomach. This supports the strategy of delivering bitter compounds past the stomach to trigger satiety.
* **Gastric Fundus:** High expression of TAS2R14, TAS2R10, and TAS2R43.
**3.2. Inter-Individual Variation ("Gut Super Tasters") (Figure 2)**
Cluster analysis identified two distinct archetypes of gut chemosensing.
* **Standard Responders:** The majority of participants showed a standard profile of receptor expression.
* **High Responders (Archetype 2):** A subset of individuals (4 out of 28) displayed a "more complete" TAS2R profile, consistently expressing receptors (TAS2R16, 39, 42, 7, 8, 9) that were below the limit of detection in others. This suggests the existence of "Gut Super Tasters" who may be more sensitive to bitter stimuli.
**3.3. Cytogenetic Variation (Figure 3)**
Receptors located on the same chromosomal region showed similar expression patterns.
* **12p13 Cluster:** Includes TAS2R14, TAS2R43, TAS2R10. High transcription in Gastric Fundus and Terminal Ileum.
* **7q35 Cluster:** Includes TAS2R41 and TAS2R60. Notably different profile, with transcription primarily in the **Small Intestine**.
### 4. Discussion
This study confirms that human TAS2Rs are expressed throughout the GI tract but exhibit significant regional variation.
* **Satiety Signaling:** The high expression of TAS2R38 and TAS2R14 in the small intestine aligns with the release sites of GLP-1 and PYY. Stimulating these specific receptors is likely the mechanism by which bitter agonists reduce food intake.
* **Individual Variability:** The identification of "Gut Super Tasters" provides a biological basis for why some individuals may experience more potent appetite suppression from bitter extracts than others.
### 5. References
1. Psichas, A., et al., Gut chemosensing mechanisms. *J Clin Invest*, 2015. 125(3): p. 908-17.
2. Al Massadi, O., et al., Macronutrients act directly on the stomach to regulate gastric ghrelin release. *J Endocrinol Invest*, 2010. 33(9): p. 599-602.
3. Janssen, S., et al., Bitter taste receptors and alpha-gustducin regulate the secretion of ghrelin. *Proc Natl Acad Sci U S A*, 2011. 108(5): p. 2094-9.
4. Feng, X., et al., Effects on glucagon-like peptide-1 secretion by distal ileal administration of nutrients. *Obes Surg*, 2013. 23(11): p. 1774-82.
5. Diez-Sampedro, A., et al., A glucose sensor hiding in a family of transporters. *Proc Natl Acad Sci U S A*, 2003. 100(20): p. 11753-8.
6. Jang, H.J., et al., Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. *Proc Natl Acad Sci U S A*, 2007. 104(38): p. 15069-74.
7. Tolhurst, G., et al., Short-chain fatty acids stimulate glucagon-like peptide-1 secretion. *Diabetes*, 2012. 61(2): p. 364-71.
8. Avau, B. and I. Depoortere, The bitter truth about bitter taste receptors. *Acta Physiol (Oxf)*, 2015.
9. Meyerhof, W., et al., The molecular receptive ranges of human TAS2R bitter taste receptors. *Chem Senses*, 2010. 35(2): p. 157-70.
10. Beauchamp, G.K. and J.A. Mennella, Flavor perception in human infants. *Digestion*, 2011. 83 Suppl 1: p. 1-6.
11. Rozin, P. and T.A. Vollmecke, Food likes and dislikes. *Annu Rev Nutr*, 1986. 6: p. 433-56.
12. Latorre, R., et al., Expression of the Bitter Taste Receptor, T2R38, in Enteroendocrine Cells. *PLoS One*, 2016. 11(2): p. e0147468.
13. Gunawardene, A.R., et al., Classification and functions of enteroendocrine cells. *Int J Exp Pathol*, 2011. 92(4): p. 219-31.
14. Sternini, C., et al., Enteroendocrine cells: a site of ‘taste’ in gastrointestinal chemosensing. *Curr Opin Endocrinol Diabetes Obes*, 2008. 15(1): p. 73-8.
15. Moran, G.W., et al., Enteroendocrine cells: neglected players in gastrointestinal disorders? *Therap Adv Gastroenterol*, 2008. 1(1): p. 51-60.
16. Posovszky, C. and M. Wabitsch, Regulation of appetite, satiation, and body weight by enteroendocrine cells. *Horm Res Paediatr*, 2015. 83(1): p. 1-10.
17. Walker, E., et al., New Zealand Bitter Hops Extract Reduces Hunger During a 24 h Water Only Fast. *Nutrients*, 2019. 11(11).
18. Walker, E.G., et al., An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion. *Am J Clin Nutr*, 2022. 115(3): p. 925-940.
19. Walker, E., K. Lo, and P. Gopal, Gastrointestinal delivery of bitter hop extract reduces appetite and food cravings. *Obes Pillars*, 2024. 11: p. 100117.
20. Sakai, H., et al., Denatonium and 6-n-Propyl-2-thiouracil... Inhibit Contraction of Various Types of Smooth Muscles. *Biol Pharm Bull*, 2016. 39(1): p. 33-41.
21. Clark, A.A., et al., Extraoral bitter taste receptors as mediators of off-target drug effects. *FASEB J*, 2012. 26(12): p. 4827-31.
22. Jeon, T.I., et al., Gut bitter taste receptor signalling induces ABCB1. *Biochem J*, 2011. 438(1): p. 33-7.
23. Liszt, K.I., et al., Human intestinal bitter taste receptors regulate innate immune responses. *J Clin Invest*, 2022. 132(3).
24. Lei, H., et al., Tuft cells utilize taste signaling molecules to respond to the pathobiont microbe. *Front Immunol*, 2023. 14: p. 1259521.
25. Schneider, C., et al., Regulation of immune responses by tuft cells. *Nat Rev Immunol*, 2019. 19(9): p. 584-593.
26. Gustafsson, J.K. and M.E.V. Johansson, The role of goblet cells and mucus in intestinal homeostasis. *Nat Rev Gastroenterol Hepatol*, 2022. 19(12): p. 785-803.
27. Gassler, N., Paneth cells in intestinal physiology and pathophysiology. *World J Gastrointest Pathophysiol*, 2017. 8(4): p. 150-160.
28. Wu, S.V., et al., Expression of bitter taste receptors of the T2R family in the gastrointestinal tract. *Proc Natl Acad Sci U S A*, 2002. 99(4): p. 2392-7.
29. Rozengurt, N., et al., Colocalization of the alpha-subunit of gustducin with PYY and GLP-1. *Am J Physiol Gastrointest Liver Physiol*, 2006. 291(5): p. G792-802.
30. Kaji, I., et al., Secretory effects of a luminal bitter tastant. *Am J Physiol Gastrointest Liver Physiol*, 2009. 296(5): p. G971-81.
31. Le Neve, B., et al., The steroid glycoside H.g.-12... activates the human bitter receptor TAS2R14. *Am J Physiol Gastrointest Liver Physiol*, 2010. 299(6): p. G1368-75.
32. Descamps-Sola, M., et al., Bitter taste receptors along the gastrointestinal tract. *Front Nutr*, 2023. 10: p. 1215889.
33. Nolden, A.A., et al., Differential bitterness in capsaicin, piperine, and ethanol. *Physiol Behav*, 2016. 156: p. 117-27.
34. Kauer, J., et al., Adult picky eating. *Appetite*, 2015. 90: p. 219-28.
35. Green, E., et al., Neural correlates of taste and pleasantness evaluation. *Brain Res*, 2015. 1620: p. 57-71.
36. Mennella, J.A., Ontogeny of taste preferences. *Am J Clin Nutr*, 2014. 99(3): p. 704S-11S.
37. Dotson, C.D., et al., Bitter taste receptors influence glucose homeostasis. *PLoS One*, 2008. 3(12): p. e3974.
38. Kok, B.P., et al., Intestinal bitter taste receptor activation alters hormone secretion. *Mol Metab*, 2018. 16: p. 76-87.
39. Liszt, K.I., et al., Caffeine induces gastric acid secretion via bitter taste signaling. *Proc Natl Acad Sci U S A*, 2017. 114(30): p. E6260-E6269.
40. Lee, R.J., et al., T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection. *J Clin Invest*, 2012. 122(11): p. 4145-59.
41. Verbeurgt, C., et al., The human bitter taste receptor T2R38 is broadly tuned for bacterial compounds. *PLoS One*, 2017. 12(9): p. e0181302.
42. Egerod, K.L., et al., A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY. *Endocrinology*, 2012. 153(12): p. 5782-95.
43. Harada, Y., et al., Role of Bitter Taste Receptors in Regulating Gastric Accommodation. *J Pharmacol Exp Ther*, 2019. 369(3): p. 466-472.
44. Kuwahara, A., Involvement of the gut chemosensory system in the regulation of colonic anion secretion. *Biomed Res Int*, 2015. 2015: p. 403919.
45. Lossow, K., et al., Comprehensive Analysis of Mouse Bitter Taste Receptors. *J Biol Chem*, 2016. 291(29): p. 15358-77.
46. Thalmann, S., et al., Major haplotypes of the human bitter taste receptor TAS2R41. *Biochem Biophys Res Commun*, 2013. 435(2): p. 267-73.
47. Fiebich, B.L. and K. Appel, Anti-inflammatory effects of willow bark extract. *Clin Pharmacol Ther*, 2003. 74(1): p. 96.
48. Saller, R., et al., Pain Relief with a Proprietary Extract of Willow Bark. *Swiss Journal of Integrative Medicine*, 2008. 20(3): p. 156-162.
49. Widmayer, P., et al., High fat feeding affects the number of GPR120 cells. *Front Physiol*, 2015. 6: p. 53.
50. Roudnitzky, N., et al., Receptor Polymorphism and Genomic Structure Interact to Shape Bitter Taste Perception. *PLoS Genet*, 2015. 11(9): p. e1005530.
51. Prandi, S., et al., Expression profiling of Tas2r genes reveals a complex pattern. *Cell Mol Life Sci*, 2018. 75(1): p. 49-65.
52. Khan, M., et al., Regulation of the probability of mouse odorant receptor gene choice. *Cell*, 2011. 147(4): p. 907-21.
53. Behrens, M., et al., Immunohistochemical detection of TAS2R38 protein. *PLoS One*, 2012. 7(7): p. e40304.
54. Veldman-Jones, M.H., et al., Evaluating Robustness and Sensitivity of the NanoString Technologies. *Cancer Res*, 2015. 75(13): p. 2587-93.